FDA: Tamiflu patients need monitoring (Associated Press)
14th Nov 2006, 03:40 GMT
Patients who take Tamiflu should be closely monitored for signs of abnormal behavior, health officials said Monday in announcing an updated label for the flu drug.
FDA: Tamiflu patients need monitoring (Associated Press) related news:
- FDA urges monitoring of Tamiflu patients — Boston Globe -- National News
- FDA: Tamiflu Patients Need Monitoring — AP Top Headlines At 5:40 p.m.
- FDA: Tamiflu patients need monitoring (AP) — Yahoo! News: Top Stories
- FDA warns users of Tamiflu — madison.com - RSS
- FDA adds 'abnormal behavior' precaution to Tamiflu label — Vail Daily - Top Stories
- FDA Orders Caution Over the use of Tamiflu — NPR Topics: Nation
- FDA Posts New Tamiflu Warning — WebMD Health Headlines
- FDA Suggests New Tamiflu Warning — WSJ.com: What's News US
- Tamiflu patients should be monitored, FDA says — The Seattle Times: Horse racing
- FDA: Monitor Tamiflu Patients' Behavior — Health News: CBSnews.com
Latest news from Yahoo! Health: Health News:
- Simple steps can speed heart attack care: study (Reuters)
- Hospitals want faster heart attack care (Associated Press)
- Diabetes threatens many of world's indigenous people (Reuters)
- Fast test catches heart blockages, U.S. study shows (Reuters)
- Children showing hardening of arteries -U.S. study (Reuters)
- Children showing hardening of arteries: U.S. study (Reuters)
- Two Canada professors win right to toke up at work (Reuters)
- Results mixed on Merck's new painkiller (Associated Press)
- Group gives advice on face transplants (Associated Press)
- Diabetes drug may cut heart risks: study (Reuters)